Cargando…
Identification of 3′‐terminal 2′‐O‐methylated miRNA in plasma as a novel diagnostic biomarker of NSCLC
Autores principales: | Guo, Xu, Guo, Hongyuan, Lu, Kuan‐Chen, Yan, Xin, Chen, Jiehao, Wei, Yanting, Han, Jiayi, Sun, Wu, Hu, Huanhuan, Su, Yuanyuan, Shen, Lingyan, Zhang, Yujing, Yin, Kai, Zhang, Chen‐Yu, Fu, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667623/ https://www.ncbi.nlm.nih.gov/pubmed/37997565 http://dx.doi.org/10.1002/ctm2.1454 |
Ejemplares similares
-
Early characterisation and prediction of liver diseases in pregnancy by plasma cell‐free RNAs
por: Sun, Jinghua, et al.
Publicado: (2023) -
High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer
por: Yi, Minhan, et al.
Publicado: (2021) -
No Significant Difference between Plasma miRNAs and Plasma-Derived Exosomal miRNAs from Healthy People
por: Tian, Fei, et al.
Publicado: (2017) -
Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
por: Xing, Ai-Yan, et al.
Publicado: (2021) -
Plasma C-Terminal Agrin Fragment as an Early Biomarker for Sarcopenia: Results From the GenoFit Study
por: Pratt, Jedd, et al.
Publicado: (2021)